User profiles for Matthias Brendel

PD Dr. med. Matthias Brendel, MHBA

LMU Munich
Verified email at med.uni-muenchen.de
Cited by 7030

Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE

S Parhizkar, T Arzberger, M Brendel… - Nature …, 2019 - nature.com
Coding variants in the triggering receptor expressed on myeloid cells 2 (TREM2) are associated
with late-onset Alzheimer’s disease (AD). We demonstrate that amyloid plaque seeding …

[PDF][PDF] White matter aging drives microglial diversity

…, D Fitzner, X Xiang, MJ Rossner, M Brendel… - Neuron, 2021 - cell.com
Aging results in gray and white matter degeneration, but the specific microglial responses
are unknown. Using single-cell RNA sequencing from white and gray matter separately, we …

sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

…, MÁ Araque Caballero, M Brendel… - EMBO molecular …, 2016 - embopress.org
TREM 2 is an innate immune receptor expressed on the surface of microglia. Loss‐of‐function
mutations of TREM 2 are associated with increased risk of Alzheimer's disease ( AD ). …

EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3

…, NL Albert, H Barthel, B van Berckel, M Brendel… - European journal of …, 2022 - Springer
The present procedural guidelines summarize the current views of the EANM Neuro-Imaging
Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …

Four-repeat tauopathies

TW Roesler, AT Marvian, M Brendel… - Progress in …, 2019 - Elsevier
Tau is a microtubule-associated protein with versatile functions in the dynamic assembly of
the neuronal cytoskeleton. Four-repeat (4R-) tauopathies are a group of neurodegenerative …

The FTD‐like syndrome causing TREM 2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism

G Kleinberger, M Brendel, E Mracsko, B Wefers… - The EMBO …, 2017 - embopress.org
Genetic variants in the triggering receptor expressed on myeloid cells 2 ( TREM 2) increase
the risk for several neurodegenerative diseases including Alzheimer's disease and …

Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction

M Brendel, M Högenauer, A Delker, J Sauerbeck… - Neuroimage, 2015 - Elsevier
Amyloid positron-emission-tomography (PET) offers an important research and diagnostic tool
for investigating Alzheimer's disease (AD). The majority of amyloid PET studies have used …

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

…, M Brendel… - EMBO molecular …, 2020 - embopress.org
Microglia activation is the brain's major immune response to amyloid plaques in Alzheimer's
disease (AD). Both cerebrospinal fluid (CSF) levels of soluble TREM2 (sTREM2), a …

Opposite microglial activation stages upon loss of PGRN or TREM 2 result in reduced cerebral glucose metabolism

JK Götzl, M Brendel, G Werner, S Parhizkar… - EMBO molecular …, 2019 - embopress.org
Microglia adopt numerous fates with homeostatic microglia ( HM ) and a microglial
neurodegenerative phenotype ( MG nD) representing two opposite ends. A number of variants in …

A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models

…, C Haass, JW Lewcock, G Di Paolo, M Brendel… - Nature …, 2023 - nature.com
Loss-of-function variants of TREM2 are associated with increased risk of Alzheimer’s disease
(AD), suggesting that activation of this innate immune receptor may be a useful therapeutic …